BACKGROUND: Reports that septic shock incidence is rising and mortality rates declining may be confounded by improving recognition of sepsis and changing coding practices. We compared trends in septic shock incidence and mortality in academic hospitals using clinical vs claims data.
Septic shock is the most severe form of sepsis and accounts for much of its morbidity and mortality. 1 Tracking trends in septic shock incidence and outcomes is critical to informing the allocation of health-care resources and interpreting the impact of sepsis prevention and treatment initiatives. However, it remains unclear whether claims-based reports of dramatic rises in sepsis and septic shock incidence and declining case fatality rates reflect more infections, better recognition, more aggressive treatment, and/or more comprehensive coding. [2] [3] [4] The recently updated consensus definition for septic shock now includes requirements for vasopressor-dependent hypotension. 5 A standardized definition based on vasopressor administration and suspected infection could facilitate measurements of incidence and mortality in clinically treated septic shock, using electronic health record (EHR) data. EHR-based algorithms for sepsis have been validated on the basis of large clinical data repositories and may be more resistant to changes in diagnosis and coding practices over time than claims data. [6] [7] [8] We examined 10-year trends in septic shock incidence and mortality at 27 US academic medical centers, using EHR clinical data vs claims data. We hypothesized that a clinical surveillance definition based on concurrent vasopressors, antibiotics, and blood cultures could provide an objective and consistent method for tracking septic shock trends over time, and that changes in incidence and mortality calculated using this definition would be less dramatic than those suggested by claims-based analyses.
Methods

Study Design
This was a retrospective cohort study using data from the University HealthSystem Consortium (UHC). The study was approved by the Institutional Review Board at Partners Healthcare (Boston, MA) (Protocol #2012P002136) and MedStar Georgetown University Hospital (Washington, DC) (Protocol #2014-1298). The study was exempt from institutional review board review at the National Institutes of Health Clinical Center, as National Institutes of Health investigators had access only to de-identified data.
Data Source and Population
The UHC is a collaborative of 120 academic medical centers with 300 affiliated hospitals. The UHC Clinical Database/Resource Manager (CDB/RM) combines patient encounter level and line-item transactional detail from all hospitals (see e-Appendix 1 for additional details). The CDB/RM is used for quality improvement and research purposes, including prior epidemiological studies of sepsis and trends in antibiotic use. [9] [10] [11] We included all adults hospitalized from January 1, 2005, through December 31, 2014 at all 27 UHC academic medical centers with continuous reporting of pharmacy data during this time period. We compared characteristics of these academic teaching hospitals with all US teaching hospitals reporting membership in the Council of Teaching Hospitals and Health Systems in the 2014 American Hospital Association database to assess generalizability.
Septic Shock Surveillance Definition
Our clinical surveillance definition required evidence of shock (as evidenced by vasopressors) and concurrent presumed infection (blood culture orders and $ 4 days of antibiotics or antifungals) ( Table 1) . We required two consecutive days of vasopressors rather than one to increase specificity for true shock by reducing potential false positives from vasopressors administered for transient hypotension. We also hoped to mitigate the effect of any changes in thresholds for using vasopressors over time by focusing on patients with persistent shock. We did, however, perform a sensitivity analysis with a definition requiring only 1 day of vasopressors to see how this affected performance and trends. Additional sensitivity analyses were also conducted using definitions requiring longer durations of antibiotic/antifungal use (7 days), changing the center of the surveillance period from the first vasopressor day to the first blood culture day, and varying the surveillance period from AE 1 day 
Presumed infection
Blood culture order on day -2 to day þ2 New parenteral antibiotic or antifungal medication administered on day -2 to day þ2 Any systemic antibiotic or antifungal medication (oral or parenteral) administered for an additional 3 days, or until 1 day prior to death if death occurs before 4 days have elapsed to AE 3 days. For comparison, we identified patients with primary or secondary International Classification of Diseases, 9th edition (ICD-9) diagnosis codes for septic shock (785.52). Last, we also examined hospitalizations with either the septic shock ICD-9 code or clinical surveillance criteria.
Validation by Medical Record Review
We examined the accuracy of the clinical surveillance definition and the ICD-9 septic shock code relative to medical record review at three academic hospitals: Massachusetts General Hospital (MGH) and Brigham and Women's Hospital (BWH) in Boston, Massachusetts, and MedStar Georgetown University Hospital (GUH) in Washington, DC. Chart reviews were performed at MGH and BWH as previously described. 8 Briefly, the charts of 1,000 patients hospitalized from 2003 to 2012 with at least one blood culture ordered were randomly selected for review by an intensivist using a structured data abstraction form, and assessed for sepsis or septic shock. Septic shock was defined as vasopressor-dependent refractory hypotension caused by suspected or confirmed infection in the absence of a clear alternative explanation for hypotension. 12, 13 Seven hundred of these hospitalizations from 2006 to 2012 that matched CDB/RM records were used for the current analysis. A second intensivist reviewed a subset of 60 records to measure concordance using the k statistic. At GUH, two internal medicine physicians reviewed 267 hospitalizations from 2009 to 2014 with any vasopressor order. Both physicians reviewed 30 randomly selected charts and a k statistic was calculated; differences were reconciled between the reviewers and a final classification agreed on.
Incidence, Mortality, and Coding Trends
We calculated annual incidence and in-hospital mortality of patients meeting the clinical and ICD-9-based definitions for 2005-2014. We also analyzed the combined outcome of in-hospital mortality and discharge to hospice. We calculated the annual proportion of patients meeting the clinical surveillance definition and who received an ICD-9 code for septic shock to estimate whether the likelihood of diagnosing septic shock has changed over time.
Statistical Analyses
Exact 95% binomial CIs were calculated for pooled sensitivity, specificity, positive predictive value, and negative predictive value for the surveillance definitions and ICD-9 codes relative to chart review. Tenyear trends were assessed by fitting time series models with linear trends to the observed annual rates. The 10-year fitted percent change for incidence was calculated as the ratio between the fitted absolute annual change multiplied by 10 and the observed baseline incidence rate in 2005. Trends from clinical data and ICD-9 codes were compared via z score by dividing the difference between each slope by the square root of the sum of the variance of each fitted trend line. We considered P < .05 to be statistically significant and used two-sided tests. All analyses were performed with SAS version 9.4 (SAS Institute).
Results
From 2005 to 2014, there were 6,526,636 adult hospitalizations in the 27 study hospitals. Overall, 99,312 (1.5%) hospitalizations met the clinical criteria for septic shock, 82,350 (1.3%) had ICD-9 codes for septic shock, and 44,651 (0.7%) had both. The case-selection process is presented as a flowchart in Figure 1 . Patients identified by both methods were similar in terms of age and comorbidities, but those identified on the basis of clinical criteria alone had longer hospital and ICU lengths of stay and higher hospital mortality rates that those identified by claims alone ( Table 2 ). The characteristics of study hospitals mirrored those reported for all US academic hospitals ( Table 3) .
Accuracy of Clinical Surveillance Definition vs Claims Code for Septic Shock
The accuracy of the clinical surveillance definition vs the ICD-9 code for septic shock is summarized in Table 4 . At MGH and BWH, there were 54 clinician-confirmed cases of septic shock among the 700 reviewed hospitalizations with blood culture draws. At GUH, 93 of the 267 hospitalized patients administered vasopressors had confirmed septic shock. Agreement between the two reviewers at MGH and BWH and between the two reviewers at GUH was good (k, 0.80 and 0.73, respectively). Of the 93 patients with confirmed septic shock at GUH, 91 (97.8%) had at least one blood culture drawn during hospitalization. The pooled sensitivity for clinician-confirmed septic shock was higher for the clinical surveillance definition than for ICD-9 codes (74.8% vs 48.3%; P < .01). The clinical definition also had excellent specificity, albeit slightly lower than ICD-9 codes (97.2% vs 98.9%; P ¼ .01).
Positive predictive values were comparable and high for both the clinical definition and for ICD-9 codes (82.7% vs 88.8%; P ¼ .23). On sensitivity analysis, the definition requiring only 1 day of vasopressors had higher sensitivity (88.4%) but lower positive predictive value (65.3%) than the definition requiring 2 days of vasopressors.
Trends
The incidence of septic shock, using clinical data, rose from 12.8 per 1,000 hospitalizations in 2005 to 18.6 in 2014 (average, 4.9% increase/y; 95% CI, 4.0%-5.9%; P < .01 for linear trend), whereas the incidence of cases identified by ICD-9 codes increased from 6.7 to 19.3 per 1,000 hospitalizations over the same period (19.8% increase/y; 95% CI, 16.6%-20.9%; P < .01 for linear trend) (Fig 2) . In-hospital mortality for septic shock identified by the clinical definition decreased from 54.9% in 2005 to 50.7% in 2014 (average decline of 0.60%/y; 95% CI, 0.40%-0.80%; P ¼ .01 for linear trend) (Fig 3) . In contrast, in-hospital mortality for cases identified by ICD-9 codes decreased from 48.3% to 39.3% (1.22%/y decline; 95% CI, 0.90%-1.55%; P < .01).
For the definition requiring 1 day of vasopressors, incidence increased from 23.0 to 35.3 (average, 5.4% increase/y; 95% CI, 4.5%-6.2%; P < .01) while mortality declined from 36.4% to 31.0% (average, 0.60%/y; 95% CI, 0.46%-0.74%; P < .01). All incidence and mortality trends from clinical data were significantly different from ICD-9-based trends (P < .01 for all comparisons).
Additional sensitivity analyses for definitions requiring 1 or 2 days of vasopressors and varying the required number of days of antibiotics, length of the surveillance window, or the center of the surveillance window to a blood culture order (rather than a vasopressor day), produced similar accuracy and 10-year trends (e- Table 1 ). When including patients on the basis of either primary surveillance criteria or septic shock codes, trends in incidence and mortality were intermediate between those seen with clinical criteria or septic shock codes alone, with incidence rising from 15.6 to 27.5 (8.1%/y; 95% CI, 6.4%-9.7%; P < .01 for linear trend) and mortality declining from 50.1% to 40.9% (1.2%/y; 95% CI, 0.9%-1.5%; P < .01). The annual proportion of patients meeting the primary clinical surveillance definition who also received an ICD-9 code for septic shock increased steadily from 29.7% in 2005 to 55.7% in 2014 (average, 2.9% increase/y; 95% CI, 2.4%-3.3%; P < .01 for linear trend).
The percentage of patients meeting the clinical surveillance definition and who were discharged to hospice increased from 0.9% in 2005 to 3.0% in 2014 (P < .01 for linear trend). When examining the combined outcome of in-hospital mortality and discharge to hospice, the apparent decline over time was attenuated for all surveillance methods. The rate of this combined outcome decreased from 55.9% to 53.7% for the primary clinical surveillance definition requiring 2 days of vasopressors (average, 0.35% decline/y; 95% CI, 0.18%-0.53%; P ¼ .25 vs mortality trend alone), from 49.5% to 42.8% for ICD-9 codes (average, 0.98% decline/y; 95% CI, 0.71, 1.25%; P ¼ .07 vs mortality trend), and from 37.6% to 34.2% for the definition requiring 1 day of vasopressors (average, 0.38% decline/y; 95% CI, 0.24%-0.52%; P ¼ .02 vs mortality trend).
Discussion
The incidence of patients with discharge codes or clinical markers indicative of treated septic shock steadily rose during the 10-year surveillance period, and in-hospital mortality for this population declined. The magnitude of these trends was considerably less when using clinical data compared with claims codes. The mortality decline was further attenuated when accounting for discharges to hospice. The likelihood of patients treated concurrently with vasopressors and antibiotics, and who provided blood samples for culturing, being coded as having septic shock has increased steadily over time. These trends were consistent in a number of sensitivity analyses, including variations in the time window required between vasopressors, antibiotics, and blood culture orders, as well as duration of antibiotics. Clinician record reviews suggested that clinical surveillance definitions for septic shock provide greater sensitivity and comparable positive predictive value than billing codes.
Our mortality estimates with the primary clinical surveillance definition are comparable, although higher, than the 42% mortality rate for the new consensus septic shock definition reported in the Surviving Sepsis Campaign database. 6 The high overall mortality estimates (50%-55%) are likely due to the requirement for two or more consecutive days of vasopressor use rather than only 1 day (mortality estimates of 31%-36%).
The definition requiring only 1 day of vasopressors had higher sensitivity for septic shock but lower specificitylikely due to the inclusion of patients who may have received vasopressor boluses (rather than infusions) for transient hypotension. Requiring 2 days of vasopressors maximized positive predictive value relative to chart review, while maintaining fairly good sensitivity.
Commonly cited reasons for a rise in sepsis incidence include aging of the population and greater use of invasive procedures and immunosuppressive therapies. 14,15 Our study was not designed to investigate these factors, nor can we ascertain to what extent the residual increase measured by the clinical surveillance definition reflects a higher burden of septic shock vs more recognition and/or more aggressive treatment.
Recommendations from the Surviving Sepsis Campaign since the mid-2000s have encouraged enhanced detection and early use of vasopressors for patients with refractory hypotension. 16, 17 This may account for some of the observed increase in patients treated for septic shock and the possible decline in mortality. In addition, some of the decrease in hospital mortality observed in our study can be attributed to a rise in the fraction of patients discharged to hospice. Not accounting for this evolving societal preference can exaggerate the overall impression of improving outcomes. 18 The imperfect sensitivity of codes as well as our clinical surveillance definition suggests that both methods may still underestimate the true burden of septic shock. Given the high specificity of both septic shock codes and clinical surveillance criteria, combining both in a surveillance definition may allow better estimates of the point prevalence of septic shock. However, the observed discrepancy in the rate of rise in septic shock incidence generated by both methods, and the rising proportion of patients meeting the clinical definition and who were coded as having septic shock, indicate that claims-based journal.publications.chestnet.org trends are confounded by more recognition and coding rather than by a true increase in disease rates. This phenomenon likely reflects rising awareness of the importance of sepsis, coupled with changing financial and policy incentives. 2, 3 More inclusive coding for sepsis/septic shock and organ dysfunction may also be exaggerating apparent declines in mortality. 4, 19 Although improvements in documentation and coding are desirable goals, the changeability of coding in response to various incentives presents a challenge for longitudinal sepsis surveillance. Reliably assessing sepsis trends is critical, particularly in light of national performance improvement initiatives and quality metrics mandated by the Centers for Medicare and Medicaid Services. Our prior work at two hospitals showed that a surveillance definition using EHR markers of presumed infection and concurrent organ dysfunction (vasopressors, initiation of mechanical ventilation, and/ or changes in patients' baseline laboratory values) also had superior sensitivity, comparable positive predictive value, and better stability over time vs claims. 8 Conducting surveillance for septic shock, compared with the entire spectrum of sepsis, is appealing as this is a more homogeneous group that can be identified by a simpler set of markers. Our surveillance definition, in its current form, contains variables that are widely available and can be easily extracted from many automated systems. Using clinical data for septic shock surveillance may mitigate surveillance bias due to transitions in coding systems and variations in coding practices, although clinical definitions may still be influenced by changes in clinical care patterns over time (such as thresholds for obtaining blood cultures or starting vasopressors).
Our study has several limitations. First, we used data from a convenience sample of academic medical centers, limiting generalizability. It is possible that the hospitals that participated in the UHC pharmacy database over the 10-year period may differ from other UHC hospitals. Future studies should examine the performance of the clinical surveillance definition in community as well as academic hospitals. Second, while charge data are not subject to the biases associated with coding practices, we were unable to confirm the accuracy of all components. Third, the adequacy of fluid resuscitation could not be determined in the absence of specific time-stamped dosage information on bolus fluid administrations. 20, 21 Fourth, it is possible that the threshold for using vasopressors is decreasing over time as a result of international guidelines emphasizing timely vasopressor use for sepsis-associated hypotension. 16, 17, 22 We required 2 days of vasopressors to mitigate the potential effect of a diminishing threshold for starting vasopressors. Similarly, trends could be confounded by variations over time in the standard practice for ordering blood cultures and prescribing antibiotics. Fifth, our data did not allow us to examine the duration of vasopressor therapy on an hour-by-hour basis, thereby allowing for the possibility of substantial heterogeneity between patients: vasopressor duration could range from several hours for an infusion started near midnight, to nearly 48 hours. Sixth, our surveillance definition closely matched the conceptual framework offered by the new consensus septic shock definition and reported death rates, but it did not include lactate testing. However, we believed this adjustment was necessary given that lactate testing rates have increased dramatically over time. 23 Requiring lactate testing in our surveillance definition would thus likely have increased false negatives in the earlier part of the 10-year surveillance period than in more recent years. Finally, our method enables reporting only on the "treated" incidence of septic shock among hospitalized patients. Our methodology could inflate incidence trends if more patients with sepsis are treated earlier with vasopressors.
In conclusion, a clinical surveillance definition based on concurrent charges for antibiotics, blood cultures, and $ 2 days of vasopressors provides greater sensitivity and comparable positive predictive value compared with medical claims data for identifying patients who receive treatment for septic shock. Applying this definition to 27 hospitals suggests the incidence of patients being treated for septic shock has risen and in-hospital mortality has declined during the 10-year surveillance period, but less dramatically than estimated using ICD-9 codes. The decrease in hospital mortality rates for patients with septic shock is partly accounted for by more patients being discharged to hospice. Surveillance based on clinical data may allow for more reliable estimates of septic shock burden and trends compared with administrative data.
